https://www.statnews.com/2020/03/19/biotech-in-the-time-of-the-coronavirus-disruptions-continue-but-theres-some-good-news-too/?utm_source=STAT+Newsletters&utm_campaign=5f59319d47-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-5f59319d47-149692869

STAT Plus: Biotech in the time of the coronavirus: Disruptions continue, but there’s some good news, too

By ADAM FEUERSTEIN

MIKE REDDY/STAT

In this edition: a Bellus Health study persists; A Pfizer-inspired plea for greater shareholder outreach; and a feel-good story from Agios Pharma.

READ MORE